Case Report
VOLUME: 36 | ISSUE: 4 | Dec 31, 2020 | PAGE: (334 - 338) | DOI: 10.24911/BioMedica/5-76
Percutaneous Cavernous Nerve Electro-Stimulation for Treatment of Erectile Dysfunction
Authors: Qing Hu , Wen-Zhi Wang , Bo-Dong Lv , Guo-Guang Lou
Article Info
Authors
Qing Hu
Department of Urology, The Second Affiliated Hospital, University of Zhejiang Traditional Chinese Medicine, Hangzhou,310005,China
Wen-Zhi Wang
Department of Urology, The Second Affiliated Hospital, University of Zhejiang Traditional Chinese Medicine, Hangzhou,310005,China
Bo-Dong Lv
Department of Urology, The Second Affiliated Hospital, University of Zhejiang Traditional Chinese Medicine, Hangzhou,310005,China
Guo-Guang Lou
Department of Urology, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou 310003, China
Publication History
Received: October 16, 2020
Revised: November 26, 2020
Accepted: December 08, 2020
Published: December 31, 2020
Abstract
Pelvic fracture urethral injury (PFUI) is the major etiological factor of neurological erectile dysfunction (NED). We reported a patient whose Index of Erectile Function-5 (IIEF-5) score was 7 (severe ED) and experienced a failed treatment of Tadalafil. NED was the final diagnosis made by examinations such as nocturnal penile tumescence (NPT), penile cavernous contrast and three-dimensional reconstruction and the penial dorsal nerve somatosensory evoked potential. Percutaneous cavernous nerve electro-stimulation was used as treatment for NED. After three courses of treatment, the IIEF-5 score was up to 18 points and the level of erection hardness was between grade III and IV. We concluded that percutaneous cavernous nerve electro-stimulation will be a new strategy to treat patients with NED with PFUI history.
Keywords: Erectile Dysfunction, Pelvic fracture urethral injury, Percutaneous nerve electro-stimulation
